Researchers Not Giving Up On Imbokodo HIV Vaccine Study

PERSISTENT researchers feel the halted HTVN 702 study on the efficacy of an HIV vaccine will not affect the Imbokodo Vaccine Trial study launched in 2017. By Kudakwashe Pembere HVTN  702 study was stopped following an interim analysis conducted on 23 January 2020 by an independent Data and Safety Monitoring Board (DSMB) that reviews all data regularly to ensure the safety of participants and determine if the study should continue. The DSMB assessment concluded that the experimental vaccine regimen used in the trial did not prevent HIV infection. The vaccine…

Share
Read More